Selective estrogen receptor modulator (SERM)
Raloxifene in Switzerland: prescription, brands, pricing
This page summarises the situation of Raloxifene in Switzerland under Swissmedic (Swiss Agency for Therapeutic Products): prescription status, available brands and generics, pharmacy dispensing, and online options in CHF. Raloxifene belongs to the Selective estrogen receptor modulator (SERM) class.
- Regulator
- Swissmedic (Swiss Agency for Therapeutic Products)
- Currency
- CHF
About Raloxifene
Raloxifene is approved for prevention and treatment of postmenopausal osteoporosis, and for reduction of invasive breast cancer risk in postmenopausal women at increased risk. Switzerland classifies medicines into categories A and B (prescription-only), C (sold under pharmacist supervision), D (over-the-counter at pharmacies and Drogerien) and E (general retail). Health insurance (Krankenversicherung) covers most prescription costs subject to a deductible (Franchise) and co-payment.
Mechanism and action
Raloxifene binds estrogen receptors and produces tissue-selective effects: estrogen-agonist activity in bone (preserving bone mineral density) and on lipid metabolism (lowering LDL cholesterol), while exhibiting estrogen-antagonist activity…
Brands and generics in Switzerland
In Switzerland, Raloxifene is typically dispensed as one internationally recognised brand along with their corresponding authorised generics. Swiss Apotheken/pharmacies are densely distributed with strict licensing; pharmacist counselling is integral to dispensing. Drogerien (drugstores) are unique to the Swiss system and sell category D and E medications without a pharmacist on staff. Brand-to-generic substitution is decided by the pharmacist under local Swissmedic (Swiss Agency for Therapeutic Products) equivalence rules, and the price difference in CHF is usually substantial.
Online and tele-prescribing access
Swiss online prescription dispensing is regulated by cantonal law, with Swissmedic-licensed services offering tele-prescribing. Cross-border importation for personal use is restricted to small quantities and excludes some controlled substances. For Raloxifene specifically, the legal online options in Switzerland depend on its Rx-or-OTC classification under Swissmedic (Swiss Agency for Therapeutic Products).
Frequently asked questions
Is Raloxifene available in Switzerland? ▾
Yes — Raloxifene and its brands are available in Switzerland through pharmacies authorised by Swissmedic (Swiss Agency for Therapeutic Products), in various strengths depending on the commercial product. Authorised generics offer a lower-cost alternative with the same active substance.
Do I need a prescription for Raloxifene in Switzerland? ▾
Switzerland classifies medicines into categories A and B (prescription-only), C (sold under pharmacist supervision), D (over-the-counter at pharmacies and Drogerien) and E (general retail). Health insurance (Krankenversicherung) covers most prescription costs subject to a deductible (Franchise) and co-payment. The exact status of Raloxifene (Rx or OTC) is determined by Swissmedic (Swiss Agency for Therapeutic Products); most active ingredients in the Selective estrogen receptor modulator (SERM) class require prescription, although there are exceptions by country and formulation.
How much does Raloxifene cost in Switzerland? ▾
The price in CHF depends on the manufacturer (brand vs authorised generic), the strength and the pack size. Generics are typically substantially cheaper than brands and serve as the economic reference for ongoing use.
Products with Raloxifene in Switzerland
Raloxifene in other countries
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.